Optimal management of mesh infection: Evidence and treatment options

Mesh reinforcement is generally considered the standard of care in ventral hernia repair. Infection is a common complication following ventral hernia repair. Infection extending to the mesh is a complex problem. Knowledge of current treatment strategies is necessary for surgeons performing abdominal...

Full description

Bibliographic Details
Main Authors: Michael R Arnold, Angela M Kao, Korene K Gbozah, B Todd Heniford, Vedra A Augenstein
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:International Journal of Abdominal Wall and Hernia Surgery
Subjects:
Online Access:http://www.herniasurgeryjournal.org/article.asp?issn=2589-8736;year=2018;volume=1;issue=2;spage=42;epage=49;aulast=Arnold
_version_ 1818936567299833856
author Michael R Arnold
Angela M Kao
Korene K Gbozah
B Todd Heniford
Vedra A Augenstein
author_facet Michael R Arnold
Angela M Kao
Korene K Gbozah
B Todd Heniford
Vedra A Augenstein
author_sort Michael R Arnold
collection DOAJ
description Mesh reinforcement is generally considered the standard of care in ventral hernia repair. Infection is a common complication following ventral hernia repair. Infection extending to the mesh is a complex problem. Knowledge of current treatment strategies is necessary for surgeons performing abdominal wall reconstruction. A comprehensive literature review was performed of current literature to assess risk factors and treatment options for mesh infection. Modifiable risk factors for mesh infections include active smoking, poorly controlled diabetes mellitus, abdominal skin or wound issues, and obesity. Operative factors that increase the risk of mesh infection include prior hernia repair, enterotomy and contamination of the surgical field. Of the synthetic meshes, lightweight polypropylene has the highest likelihood of salvage. Patients that are current smokers, those with other synthetic mesh types, and those infected with MRSA are rarely salvaged. Following excision of infected mesh, multi-staged abdominal wall reconstruction can be considered. Biologic or biosynthetic mesh is recommended when repairing incisional hernias following excision of infected mesh and likely represent the patient's best chance at a definitive hernia repair. Wound VAC-assisted delayed primary closure should be considered in higher-risk patients. Mesh infection is a complex complication that is commonly encountered by surgeons performing hernia repair. Prevention through patient optimization should be performed whenever appropriate. However, when patients develop a mesh infection, most will require complete mesh excision and recurrent hernia repair.
first_indexed 2024-12-20T05:38:07Z
format Article
id doaj.art-373f0f336e4743509348841f307db6b9
institution Directory Open Access Journal
issn 2589-8078
language English
last_indexed 2024-12-20T05:38:07Z
publishDate 2018-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series International Journal of Abdominal Wall and Hernia Surgery
spelling doaj.art-373f0f336e4743509348841f307db6b92022-12-21T19:51:31ZengWolters Kluwer Medknow PublicationsInternational Journal of Abdominal Wall and Hernia Surgery2589-80782018-01-0112424910.4103/ijawhs.ijawhs_16_18Optimal management of mesh infection: Evidence and treatment optionsMichael R ArnoldAngela M KaoKorene K GbozahB Todd HenifordVedra A AugensteinMesh reinforcement is generally considered the standard of care in ventral hernia repair. Infection is a common complication following ventral hernia repair. Infection extending to the mesh is a complex problem. Knowledge of current treatment strategies is necessary for surgeons performing abdominal wall reconstruction. A comprehensive literature review was performed of current literature to assess risk factors and treatment options for mesh infection. Modifiable risk factors for mesh infections include active smoking, poorly controlled diabetes mellitus, abdominal skin or wound issues, and obesity. Operative factors that increase the risk of mesh infection include prior hernia repair, enterotomy and contamination of the surgical field. Of the synthetic meshes, lightweight polypropylene has the highest likelihood of salvage. Patients that are current smokers, those with other synthetic mesh types, and those infected with MRSA are rarely salvaged. Following excision of infected mesh, multi-staged abdominal wall reconstruction can be considered. Biologic or biosynthetic mesh is recommended when repairing incisional hernias following excision of infected mesh and likely represent the patient's best chance at a definitive hernia repair. Wound VAC-assisted delayed primary closure should be considered in higher-risk patients. Mesh infection is a complex complication that is commonly encountered by surgeons performing hernia repair. Prevention through patient optimization should be performed whenever appropriate. However, when patients develop a mesh infection, most will require complete mesh excision and recurrent hernia repair.http://www.herniasurgeryjournal.org/article.asp?issn=2589-8736;year=2018;volume=1;issue=2;spage=42;epage=49;aulast=Arnoldherniainfectionmanagementmeshtreatment
spellingShingle Michael R Arnold
Angela M Kao
Korene K Gbozah
B Todd Heniford
Vedra A Augenstein
Optimal management of mesh infection: Evidence and treatment options
International Journal of Abdominal Wall and Hernia Surgery
hernia
infection
management
mesh
treatment
title Optimal management of mesh infection: Evidence and treatment options
title_full Optimal management of mesh infection: Evidence and treatment options
title_fullStr Optimal management of mesh infection: Evidence and treatment options
title_full_unstemmed Optimal management of mesh infection: Evidence and treatment options
title_short Optimal management of mesh infection: Evidence and treatment options
title_sort optimal management of mesh infection evidence and treatment options
topic hernia
infection
management
mesh
treatment
url http://www.herniasurgeryjournal.org/article.asp?issn=2589-8736;year=2018;volume=1;issue=2;spage=42;epage=49;aulast=Arnold
work_keys_str_mv AT michaelrarnold optimalmanagementofmeshinfectionevidenceandtreatmentoptions
AT angelamkao optimalmanagementofmeshinfectionevidenceandtreatmentoptions
AT korenekgbozah optimalmanagementofmeshinfectionevidenceandtreatmentoptions
AT btoddheniford optimalmanagementofmeshinfectionevidenceandtreatmentoptions
AT vedraaaugenstein optimalmanagementofmeshinfectionevidenceandtreatmentoptions